{"ticker": {"uuid": "b23c6d64-6c72-4cae-b7ff-961a54bda475", "symbol": "CYRX", "name": "Cryoport Inc", "exchange": "NASDAQ", "country": "US", "sector": "Industrials", "industry": "Integrated Freight & Logistics"}, "articles": [{"title": "(CYRX) as a Liquidity Pulse for Institutional Tactics", "summary": "This article analyzes Cryoport Inc. (NASDAQ: CYRX), indicating a strong sentiment across all horizons and significant upside potential due to the absence of resistance levels above the current price. It presents three AI-generated institutional trading strategies: a Position Trad", "url": "https://news.stocktradersdaily.com/news_release/151/CYRX_as_a_Liquidity_Pulse_for_Institutional_Tactics_071426034402_1784015042.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-14T03:40:17", "published_display": "14 Jul 2026 03:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SG Americas Securities LLC Cuts Stock Holdings in CryoPort, Inc. $CYRX", "summary": "SG Americas Securities LLC significantly reduced its stake in CryoPort (NASDAQ:CYRX) by 87.2% in the first quarter, now holding 15,252 shares worth $126,000. Despite this, several analysts maintain a \"Moderate Buy\" rating for CryoPort with an average price target of $15.11, and t", "url": "https://www.marketbeat.com/instant-alerts/filing-sg-americas-securities-llc-cuts-stock-holdings-in-cryoport-inc-cyrx-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T09:10:02", "published_display": "13 Jul 2026 09:10", "sentiment": "negative", "sentiment_pct": 41, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CYRX stock stays supported by cold chain demand and biotech logistics growth", "summary": "Cryoport Inc. (CYRX) specializes in temperature-controlled logistics for advanced biopharmaceuticals and reproductive medicine, including cell and gene therapies. The company's stock is supported by the expanding demand for reliable cold chain solutions in the life sciences secto", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cyrx-stock-stays-supported-by-cold-chain-demand-and-biotech-logistics/69733955", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T17:18:00", "published_display": "09 Jul 2026 17:18", "sentiment": "positive", "sentiment_pct": 73, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort (NASDAQ:CYRX) Stock Crosses Above Two Hundred Day Moving Average - Here's Why", "summary": "CryoPort (NASDAQ:CYRX) stock crossed above its 200-day moving average, reaching $15.28, a 1.3% gain. Analysts generally hold a \"Moderate Buy\" rating with a consensus target of $15.11, though insider selling has been observed with over 227,000 shares sold recently. The company, a ", "url": "https://www.marketbeat.com/instant-alerts/cryoport-nasdaqcyrx-stock-crosses-above-two-hundred-day-moving-average-heres-why-2026-07-09/", "source_name": "MarketBeat", "published_at": "2026-07-09T08:12:54", "published_display": "09 Jul 2026 08:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc outlines its logistics role for cell and gene therapies", "summary": "Cryoport Inc specializes in providing temperature-controlled logistics for sensitive biological materials, particularly for cell and gene therapies. The company's services include cryogenic shipping systems, specialized packaging, and temperature monitoring, which are crucial for", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cryoport-inc-outlines-its-logistics-role-for-cell-and-gene-therapies/69713714", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T12:14:30", "published_display": "07 Jul 2026 12:14", "sentiment": "positive", "sentiment_pct": 80, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Investor presentation Summary", "summary": "This article summarizes Cryoport's investor presentation on June 30, 2026, highlighting its strategic positioning as a critical infrastructure provider for the cell and gene therapy industry. It covers the company's financial performance, including Q3 2024 revenue of $56.7M and f", "url": "https://quartr.com/events/cryoport-inc-cyrx-investor-presentation_FkZ6gb7b", "source_name": "Quartr", "published_at": "2026-06-30T03:11:05", "published_display": "30 Jun 2026 03:11", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort, Inc. Actuals & Estimates (NASDAQ:CYRX)", "summary": "This article provides an overview of CryoPort, Inc. (NASDAQ: CYRX) financials, analyst estimates, and stock performance. It details the company's current stock price, market capitalization, earnings, and revenue, alongside analyst price targets and historical highs and lows. The ", "url": "https://www.tradingview.com/symbols/NASDAQ-CYRX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T10:09:28", "published_display": "27 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of CryoPort, Inc. \u2013 NASDAQ:CYRX", "summary": "This article focuses on the enterprise value to revenue forward metric for CryoPort, Inc. (NASDAQ:CYRX). It presents key financial data and market information related to the company's valuation. The content appears to be a financial snapshot provided by TradingView, detailing var", "url": "https://www.tradingview.com/symbols/NASDAQ-CYRX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T09:40:30", "published_display": "27 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort, Inc. $CYRX Shares Bought by Penbrook Management LLC", "summary": "Penbrook Management LLC significantly increased its stake in CryoPort, Inc. (NASDAQ:CYRX) by 251.6% in the first quarter, adding 132,940 shares. Other institutional investors like AQR Capital Management LLC and Creative Planning also adjusted their positions, with 92.90% of the s", "url": "https://www.marketbeat.com/instant-alerts/filing-cryoport-inc-cyrx-shares-bought-by-penbrook-management-llc-2026-06-26/", "source_name": "MarketBeat", "published_at": "2026-06-27T09:40:30", "published_display": "27 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of CryoPort, Inc. \u2013 NASDAQ:CYRX", "summary": "This article provides a financial data point for CryoPort, Inc. (NASDAQ: CYRX), specifically its \"Price to book forward\" value without stating the actual value. It indicates that the data was \"Made by humans\" and lists various sources for market and reference data, including ICE ", "url": "https://www.tradingview.com/symbols/NASDAQ-CYRX/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:40:46", "published_display": "27 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of CryoPort, Inc. \u2013 MUN:CKX", "summary": "This page provides financial information for CryoPort, Inc. (CKX) on the Munich Stock Exchange, specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or a section within a larger financial data platform.", "url": "https://www.tradingview.com/symbols/MUN-CKX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T14:40:24", "published_display": "26 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs", "summary": "Cryoport, a leading provider of temperature-controlled supply chain solutions for the life sciences, announced that Verismo Therapeutics has selected its IntegriCell cryopreservation services. This partnership aims to support Verismo's clinical KIR-CAR T cell therapy programs, en", "url": "https://www.moomoo.com/news/post/72035728/cryoport-s-integricell-cryopreservation-services-selected-by-verismo-therapeutics-to", "source_name": "Moomoo", "published_at": "2026-06-26T09:40:31", "published_display": "26 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Industrial Goods Companies: CryoPort (CYRX) and United Rentals (URI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxNNFhWVjFkVlZOTzR4bEFfOWNoTzYya0FtQkJqUnlxU21EdE9OUHh5c3MtWEdDS2trQ3IzTHZ2WWUxN3NQeVJuMXR5aXlnYjlLT3hsWUZleVZIVFRnaTlVVE9xNzVjNktNOGpnc2ZPRUhhbTdJdmVIVWEzb1duZ3dYNGw2cVNRSHJQUWVkTzNpNmdyaVR3Tk8tOUNVd0hXU2tZSEVPT3ZRMkpDMGRfbm5EdThVU3B1cllvNkhlSHVZZjBmcmZNQnZOZld6S3ZZbkN6bHJRd2NKX1pwaWxKUk1LRDlCS2xSZFZFZ3FoZ1MwckpBbUVCSDd1d3dxcnp4TmdSeHc?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CYRX Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for CryoPort, Inc. (CYRX) stock for 2027, based on analyst opinions. It details current stock performance, historical highs and lows, financial metrics like market capitalization, earnings, revenue, and EBITDA, and does not sugges", "url": "https://www.tradingview.com/symbols/NASDAQ-CYRX/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T05:12:12", "published_display": "26 Jun 2026 05:12", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of CryoPort, Inc. \u2013 GETTEX:CKX", "summary": "This article focuses on the enterprise value to EBITDA forward for CryoPort, Inc. (GETTEX:CKX). It appears to be a stub or data-point article from TradingView, providing financial metrics for the company within the Air Freight/Couriers sector. The content includes a brief mention", "url": "https://www.tradingview.com/symbols/GETTEX-CKX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T05:12:12", "published_display": "26 Jun 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort to Provide IntegriCell Cryopreservation Services for Verismo's Development Programs", "summary": "Cryoport Systems, a subsidiary of Cryoport, Inc., has been selected by Verismo Therapeutics to provide IntegriCell Cryopreservation services. These services will support Verismo's clinical Kir-Car T cell therapy programs. This announcement highlights Cryoport's role in supplying ", "url": "https://www.marketscreener.com/news/cryoport-to-provide-integricell-cryopreservation-services-for-verismo-s-development-programs-ce7f5fd8de8bf323", "source_name": "marketscreener.com", "published_at": "2026-06-25T13:10:58", "published_display": "25 Jun 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport's IntegriCell\u00ae Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs", "summary": "Cryoport Systems' IntegriCell cryopreservation services have been selected by Verismo Therapeutics to support its clinical KIR-CAR T cell therapy programs, SynKIR\u2122-110 and SynKIR\u2122-310. This partnership aims to standardize and scale Verismo's cryopreservation processes, ensuring c", "url": "https://www.prnewswire.com/news-releases/cryoports-integricell-cryopreservation-services-selected-by-verismo-therapeutics-to-support-clinical-kir-car-t-cell-therapy-programs-302810192.html", "source_name": "PR Newswire", "published_at": "2026-06-25T12:10:58", "published_display": "25 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport\u2019s IntegriCell selected for Verismo therapy programs By Investing.com", "summary": "Cryoport, Inc. announced that its IntegriCell cryopreservation services have been chosen by Verismo Therapeutics to support two clinical-stage CAR T cell therapy programs, SynKIR-110 and SynKIR-310, which are both in Phase 1 trials. This partnership will include process developme", "url": "https://m.au.investing.com/news/stock-market-news/cryoports-integricell-selected-for-verismo-therapy-programs-93CH-4504703?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-25T12:10:58", "published_display": "25 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport lands Verismo for clinical cell therapy cryopreservation", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPS1FmRFVqNWY5MHFvYVFoQUxlYlVsRlU3WHFweVBrUmR1UGVtLVAyS3pOWkNweW95VWZELTB0M1p1TDMtQTFCSVBEVmFWWDVlaE5QYlk4MmdOS0puNTRXUlJlVmxFa2tkZWgxZl85Tk1uaTFBUXB6NC1sdjB4aUttZXhvUU44WmZUb0R5eHp4SHhQcUxxSnFSTmpjckZQVzhxYVZzREVxd0lvRmRnaTB3dWQwcURUQ1k?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[15-12G] Cryoport, Inc. SEC Filing", "summary": "Cryoport, Inc. filed Form 15-12G with the SEC to terminate or suspend its duty to file reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934. The filing indicates the termination relies on Rule 12g-4(a)(1) and states that the warrants to purchase common stock", "url": "https://www.stocktitan.net/sec-filings/CYRX/15-12g-cryoport-inc-sec-filing-bfd4ff53185d.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:10:09", "published_display": "22 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(CYRX) Movement as an Input in Quant Signal Sets", "summary": "This article from Stock Traders Daily discusses Cryoport Inc. (NASDAQ: CYRX) and its movement within quantitative signal sets. It highlights positive near-term sentiment while noting a weak mid-term bias within a long-term strength context. The analysis provides AI-generated sign", "url": "https://news.stocktradersdaily.com/news_release/9/CYRX_Movement_as_an_Input_in_Quant_Signal_Sets_062226012402_1782105842.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-22T01:24:00", "published_display": "22 Jun 2026 01:24", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Proxy Filing Summary", "summary": "This article summarizes Cryoport's (CYRX) proxy filing, detailing the upcoming annual meeting scheduled for June 6, 2025. Shareholders will vote on the election of six directors, the ratification of Deloitte & Touche LLP as independent auditor, advisory votes on executive compens", "url": "https://quartr.com/events/cryoport-cyrx-proxy-filing_FkZ6Y8zf", "source_name": "Quartr", "published_at": "2026-06-21T09:39:08", "published_display": "21 Jun 2026 09:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Valuation: PE, PB & Fair Value Analysis", "summary": "The article provides a valuation analysis for Cryoport Inc (CYRX), noting its current valuation score is 9.89, ranking 2nd in the Freight & Logistics Services industry. It highlights the company's current P/E ratio of 10.48, which is below its recent high but significantly above ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T17:40:09", "published_display": "18 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Cryoport Inc (CYRX) has an earnings forecast score of 8.60, placing it 8th out of 77 in the Freight & Logistics Services industry. Analysts have an average price target of $13.00, with a consensus \"Buy\" rating based on 10 analysts. The company's expected revenue for the next quar", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T05:41:20", "published_display": "18 Jun 2026 05:41", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Cryoport Inc (CYRX), focusing on its support and resistance levels, various technical indicators, and moving averages. As of June 18, 2026, CYRX has a price momentum score of 7.08 and is trading between a resistance level of $16.58 an", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/technical", "source_name": "TradingKey", "published_at": "2026-06-18T05:41:20", "published_display": "18 Jun 2026 05:41", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Cryoport Inc (CYRX), listing major shareholders and their proportional holdings, as well as an analysis of shareholder types. It also provides institutional shareholding data over several quarters and recent shareholder activity w", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T05:11:03", "published_display": "18 Jun 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical data on dividends and stock splits for Cryoport Inc (CYRX). It states that no dividend data or stock split information is available for the company over the past five years. The page also includes current stock information such as market cap, P/E ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T06:40:30", "published_display": "17 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Cryoport Inc (CYRX) for fiscal year 2025. It segments the company's revenue into business lines, including Life Science products, BioLogistics solutions, and BioStorage/Bioservices, and also by geographical regions: Americas,", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T05:40:30", "published_display": "17 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Financial Health: Profitability & Balance Sheet Analysis", "summary": "The article analyzes the financial health of Cryoport Inc (CYRX), giving it a financial score of 7.34, ranking 42 out of 77 in its industry. It highlights the company's robust financial status and average operating efficiency, noting a 16.47% year-over-year increase in quarterly ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T05:09:09", "published_display": "17 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Institutional Confidence", "summary": "Cryoport Inc (CYRX) has an institutional shareholding score of 10.00, placing it first among 77 companies in the Freight & Logistics Services industry. The latest institutional shareholding proportion is 97.68%, despite a quarter-over-quarter decrease of 16.78%. First Eagle Inves", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T05:09:09", "published_display": "17 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Stock Fair Value Rises After Analysts Revisit Bioservices Outlook", "summary": "Analysts have increased Cryoport's (CYRX) fair value per share to US$15.61 from US$13.61, indicating a more positive outlook on the stock's intrinsic worth. This change is driven by recent reports focusing on bioservices operations, with discussion around differentiated offerings", "url": "https://sg.finance.yahoo.com/news/cryoport-cyrx-stock-fair-value-121105049.html", "source_name": "Market source", "published_at": "2026-06-13T12:09:18", "published_display": "13 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 78, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport chief digital and tech officer sells $507,563 in stock", "summary": "Cryoport's Chief Digital and Tech Officer, Edward J. Zecchini, sold approximately $507,563 worth of company stock across two days in June 2026. These transactions involved acquiring shares through option exercises at $4.80 each and then selling them at significantly higher market", "url": "https://www.investing.com/news/insider-trading-news/cryoport-chief-digital-and-tech-officer-sells-507563-in-stock-93CH-4740742", "source_name": "Investing.com", "published_at": "2026-06-13T03:40:22", "published_display": "13 Jun 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) tech chief exercises 35,000 options and sells shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPei1hTWU4cnZPUUZxd1hrS3Z2UEtLZlQ1ZXJtU0tFcHk2RFItX2dvMFdyMXRwTEZ4RWV3MnZsMkd1d0dNMTRhQjNydnVkNjYyREp2d1VHeUlKMGFBdmhIUF91TnlKWmZHemxLbXVqUmxzR2ZvbzlxNVhlcEZLU0FjOUpuQ2ozS29CTGgwMk55NHpVWGM4VXIyMlIwcVdMLUtMSWlfZWNNVWtwdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Cryoport, Inc. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNTHU0U0lmZ2RybFA2cG9TUV9YV0s0ODJ0UzRzZWxjSkJhdm16UWp5ZzZ6cXp1NUNxU0dFNTdLZ0VrdWNtQlZab2FmVHhGaXVSZXp0SDcxcDU5eHdsQWljV2xTSHZaZzhpeDlMcVRyWi1qbktWLWxFOGRVSi1tMFc1ZzZiaGRYRkdpVVdqdnl2VHRwNE0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Senior VP Robert Stefanovich Sold A Bunch Of Shares In Cryoport", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Insider Sold Shares Worth $2,756,984, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cryoport-insider-sold-shares-worth-071646428.html", "source_name": "MT Newswires", "published_at": "2026-06-09T07:16:46+00:00", "published_display": "09 Jun 2026 07:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (NASDAQ: CYRX) investors approve directors, pay and expanded equity plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQelp0NUpxNmhfaGJmc3NxVmJJLWdQVnpSbF9CZ3A1WnJCa3hHeVAwazVmWEtGaHVrdlZJOUR3MndYaGhxV3BTVzVKR3VxWXpxbXN6M2FrR1l0VE8xb2lZOHRRZVdsLU9PbjVvWExrRXBNWTdTUGxGakFiMXVnUUo0LU9NSUY1UnBzbTJPWHFWRE5JYkRxSFRRUHAwZ1o2cHNwZFFF?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham Raises Price Target on CryoPort to $15 From $13, Keeps Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/needham-raises-price-target-cryoport-124604962.html", "source_name": "MT Newswires", "published_at": "2026-05-05T12:46:04+00:00", "published_display": "05 May 2026 12:46", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/44a34789-b1b2-370b-9db5-af843fa8fec7/cryoport%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-05T00:23:26+00:00", "published_display": "05 May 2026 00:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/58796537-ecc4-3eae-8df9-8324684f873f/cryoport-%28cyrx%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-04T22:21:22+00:00", "published_display": "04 May 2026 22:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/9edadef3-689d-3887-9775-c9f49f5254f7/cryoport-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-04T22:17:51+00:00", "published_display": "04 May 2026 22:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Q2 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/7ae8f1e9-c196-3458-b26d-28141f1ecb63/cryoport-%28cyrx%29-q2-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-04T20:29:20+00:00", "published_display": "04 May 2026 20:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOZmRGa0RZaDYxSHpBMTdOSnNYZE43WGZWNXlfVEVrTnRCZmo2dnRIbDVDT3JkVnhsb001WXg5NzJ3dHRGbG1fb0k2bFNLY3lpMWtPM0ZFanZ3TldMWWoyd0J1c0V6b1ZKT0pfenpXTU5MbENPWVNEQ3ZoSmlaRVc3elhzTlRORVlpSW1yaHhRZXREalVSWjhFajF1VEZXSDg3bWFEN1BhOVRXekJhREE?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRYOPORT ($CYRX) Releases Q1 2026 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNUDNNN3U4RnZvVmdQdVFCOUZvMEhvMzJGZTNHYkFFSFFNTjdmYWgyZW5SdWNsNHMweGJEbmhqRktQRkQyWkJ5bUtIclNkSzhOb094dXVJbWFSdFJjTDh6UjhPLVUyUlRHWWVILW5CNDItb0kzUUhvV3pLZXFwTHBxamc5V2JsazRJQXZJeVhydXdBblM0RmF1V2hOT0Y?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2RfNFpRckdadF83VzNvekI1bTVXWDBBRmNtbjkwMXhrYU1TZDA5d2JxTDd0dl9oRUNSS2hkQXl3Q2R6Nlhtb2JrdmFTLVNqeS1aLVBadUlHZS1HT1RLbzhOakFyQlBHOTgwVV9sWkd4b2dVV2dGaFJ4QXFpbk9ZT0NhbDRRZmRQN2REZ3lEamczaTRzYUNQaQ?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Cryoport (CYRX) Story Is Shifting With Fresh Analyst Coverage And Valuation Tweaks", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQSlV5MG9KNUxWMUNuUVcwT29DSl93WUgzWnBuNTFjVDFQOVNpUllqR0RocWVjbnlsbURkTk1GVldXanF6T2U0TWpRTEtRVkNwNHhGMjNjdkVoTzFwc0Zrak1BRDQySWQySHdtTUhTOU04MUZQZUVnQ1VsaGhBRVVDWl9Tckp2alBMRnZqbnY4LVhPX1daVDB2TzhoUDFjZXF4?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport schedules May 4 earnings release, 5 p.m. investor Q&A", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbUR0YzVSa0VpN0dTd3FpSXVyT0dieUY2dE83TEpDZFQzV0hiNlhWbndHVTJtOHNDRm9ZOEFMcXNURXZKNkdIOEx5WExYTzJ0TXc0UkszcG1SVzNyQWFUcEpJME9GY0lBWVpjelAyTzM2WFhHZXdZUk5zUU9RMVVXcWY1YTEtMm5KRzEyUy1hZVdHVXdoMWltblFQYUVPN3B1MFNXSnVMaGFrM1Z2NmpSc3Y2TUdrLWIwSlZN?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven (NASDAQ:CYRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQcWNBbmZRa05RX1U5eVNjd012ZHlwd05udmJLZzJmRkRzN0dGX1RUNXg0Mk1Dem1ITUU0RVZtbFJ3ZVF0cHdadW1WX0ZDakpIOEVRbjU5NXpfTFpFOEI4ckxvcHhkdkFCQW9lSnlMendPSEgzY3RLcnZTZWVTdWQwT1dsSWtSMDMyNG80LXZZa2ZQel8yUEJmRFZYSjJTZENEalJTTWg2NFJWd2xkcGlybGhZLU1xT1E?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Freezing gene therapies for 760 trials: Cryoport's $176M year", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQMUNvOXVDa0ozclAwN3lyby1TOWxBQVoxNGhCQk5xSVlqREhWZE1xR1NEcGlWcTc0R1FDSU9uOElaTDJIbHNkZ0ZjdXR5UWFNRzR2b0VNaENJbHp3YUlHX3V4bkFaOGdhMXk4dVJWNVBYbEo4aWJqOFotckxmWG1VckZuR1hSSWR3WEExeGkyU2sxOVBGbHpDWE5nd3F3cGkzdU5teXFhY3JNSmtfaGR3cmlWRTJwdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort Inc. (CYRX) Stock Rises on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNV3hMRk5scWFDcTd3ZWZrT1g4aWxCVWlHNWgyYTg0bFg1VFRaeEF4QWUwanhDclZIWTFCRDdhOVJPYkl5UjA1eUdEaDlMXzF5aVRSbjJvMWlCU1VEMmJRRmdNdTR4TzV4djlHMVlCN0tjTk5QOVphTzJfcFRoVFFkMTVaRGdHeUhDdUl6WUJfOVQ1d28?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9pOTBUa2ZNbjFtV2U4YU8yZThnOTQxUkJVQzB2SHg0LWF6OE1VYWVLMlFzd2VQTXFxTmYzcGNsd2hSR0FEVWlpV3lSSUFoZw?oc=5", "source_name": "Stock Titan", "published_at": "2025-11-04T08:00:00+00:00", "published_display": "04 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOLVdNcXphS3JyTGVRUmlnanJkOGpwVnFGQ0JGZWM2U3hFZzFYX0tGZnd4QTRsRWRENFB1cDlHeFNrZGxJSDNSLUk5cTVSdXdWRl9TZXZKUGEtRHI5T2NDYUtqMW5fenJhTHlISDlJdVZFaDdIYmZlRTd5RGhSTmhWZGpKOHJfMmFrX1F3MFc2Z1lQLWNtUHhVQm9fYzVtVURfYlB3N0d3SkM4S09pTmRmMEpaT0Q?oc=5", "source_name": "Stock Titan", "published_at": "2024-09-25T07:00:00+00:00", "published_display": "25 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort (CYRX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE0ybV9mbktYbkpCaFFhNURSSEl6aGVnYk9YYzNRcVNtc3did1pUUWh3MkxQeDduam1NVlc2VXBSM0NTdzBOa0VHRUdKLWR3UWVGRkhUYm41emFzZw?oc=5", "source_name": "MarketBeat", "published_at": "2017-03-30T00:11:36+00:00", "published_display": "30 Mar 2017 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "(CYRX) as a Liquidity Pulse for Institutional Tactics", "summary": "This article analyzes Cryoport Inc. (NASDAQ: CYRX), indicating a strong sentiment across all horizons and significant upside potential due to the absence of resistance levels above the current price. It presents three AI-generated institutional trading strategies: a Position Trad", "url": "https://news.stocktradersdaily.com/news_release/151/CYRX_as_a_Liquidity_Pulse_for_Institutional_Tactics_071426034402_1784015042.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-14T03:40:17", "published_display": "14 Jul 2026 03:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SG Americas Securities LLC Cuts Stock Holdings in CryoPort, Inc. $CYRX", "summary": "SG Americas Securities LLC significantly reduced its stake in CryoPort (NASDAQ:CYRX) by 87.2% in the first quarter, now holding 15,252 shares worth $126,000. Despite this, several analysts maintain a \"Moderate Buy\" rating for CryoPort with an average price target of $15.11, and t", "url": "https://www.marketbeat.com/instant-alerts/filing-sg-americas-securities-llc-cuts-stock-holdings-in-cryoport-inc-cyrx-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T09:10:02", "published_display": "13 Jul 2026 09:10", "sentiment": "negative", "sentiment_pct": 41, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CYRX stock stays supported by cold chain demand and biotech logistics growth", "summary": "Cryoport Inc. (CYRX) specializes in temperature-controlled logistics for advanced biopharmaceuticals and reproductive medicine, including cell and gene therapies. The company's stock is supported by the expanding demand for reliable cold chain solutions in the life sciences secto", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cyrx-stock-stays-supported-by-cold-chain-demand-and-biotech-logistics/69733955", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T17:18:00", "published_display": "09 Jul 2026 17:18", "sentiment": "positive", "sentiment_pct": 73, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort (NASDAQ:CYRX) Stock Crosses Above Two Hundred Day Moving Average - Here's Why", "summary": "CryoPort (NASDAQ:CYRX) stock crossed above its 200-day moving average, reaching $15.28, a 1.3% gain. Analysts generally hold a \"Moderate Buy\" rating with a consensus target of $15.11, though insider selling has been observed with over 227,000 shares sold recently. The company, a ", "url": "https://www.marketbeat.com/instant-alerts/cryoport-nasdaqcyrx-stock-crosses-above-two-hundred-day-moving-average-heres-why-2026-07-09/", "source_name": "MarketBeat", "published_at": "2026-07-09T08:12:54", "published_display": "09 Jul 2026 08:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc outlines its logistics role for cell and gene therapies", "summary": "Cryoport Inc specializes in providing temperature-controlled logistics for sensitive biological materials, particularly for cell and gene therapies. The company's services include cryogenic shipping systems, specialized packaging, and temperature monitoring, which are crucial for", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cryoport-inc-outlines-its-logistics-role-for-cell-and-gene-therapies/69713714", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T12:14:30", "published_display": "07 Jul 2026 12:14", "sentiment": "positive", "sentiment_pct": 80, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Investor presentation Summary", "summary": "This article summarizes Cryoport's investor presentation on June 30, 2026, highlighting its strategic positioning as a critical infrastructure provider for the cell and gene therapy industry. It covers the company's financial performance, including Q3 2024 revenue of $56.7M and f", "url": "https://quartr.com/events/cryoport-inc-cyrx-investor-presentation_FkZ6gb7b", "source_name": "Quartr", "published_at": "2026-06-30T03:11:05", "published_display": "30 Jun 2026 03:11", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort, Inc. Actuals & Estimates (NASDAQ:CYRX)", "summary": "This article provides an overview of CryoPort, Inc. (NASDAQ: CYRX) financials, analyst estimates, and stock performance. It details the company's current stock price, market capitalization, earnings, and revenue, alongside analyst price targets and historical highs and lows. The ", "url": "https://www.tradingview.com/symbols/NASDAQ-CYRX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T10:09:28", "published_display": "27 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of CryoPort, Inc. \u2013 NASDAQ:CYRX", "summary": "This article focuses on the enterprise value to revenue forward metric for CryoPort, Inc. (NASDAQ:CYRX). It presents key financial data and market information related to the company's valuation. The content appears to be a financial snapshot provided by TradingView, detailing var", "url": "https://www.tradingview.com/symbols/NASDAQ-CYRX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T09:40:30", "published_display": "27 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort, Inc. $CYRX Shares Bought by Penbrook Management LLC", "summary": "Penbrook Management LLC significantly increased its stake in CryoPort, Inc. (NASDAQ:CYRX) by 251.6% in the first quarter, adding 132,940 shares. Other institutional investors like AQR Capital Management LLC and Creative Planning also adjusted their positions, with 92.90% of the s", "url": "https://www.marketbeat.com/instant-alerts/filing-cryoport-inc-cyrx-shares-bought-by-penbrook-management-llc-2026-06-26/", "source_name": "MarketBeat", "published_at": "2026-06-27T09:40:30", "published_display": "27 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of CryoPort, Inc. \u2013 NASDAQ:CYRX", "summary": "This article provides a financial data point for CryoPort, Inc. (NASDAQ: CYRX), specifically its \"Price to book forward\" value without stating the actual value. It indicates that the data was \"Made by humans\" and lists various sources for market and reference data, including ICE ", "url": "https://www.tradingview.com/symbols/NASDAQ-CYRX/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:40:46", "published_display": "27 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of CryoPort, Inc. \u2013 MUN:CKX", "summary": "This page provides financial information for CryoPort, Inc. (CKX) on the Munich Stock Exchange, specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or a section within a larger financial data platform.", "url": "https://www.tradingview.com/symbols/MUN-CKX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T14:40:24", "published_display": "26 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs", "summary": "Cryoport, a leading provider of temperature-controlled supply chain solutions for the life sciences, announced that Verismo Therapeutics has selected its IntegriCell cryopreservation services. This partnership aims to support Verismo's clinical KIR-CAR T cell therapy programs, en", "url": "https://www.moomoo.com/news/post/72035728/cryoport-s-integricell-cryopreservation-services-selected-by-verismo-therapeutics-to", "source_name": "Moomoo", "published_at": "2026-06-26T09:40:31", "published_display": "26 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Industrial Goods Companies: CryoPort (CYRX) and United Rentals (URI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxNNFhWVjFkVlZOTzR4bEFfOWNoTzYya0FtQkJqUnlxU21EdE9OUHh5c3MtWEdDS2trQ3IzTHZ2WWUxN3NQeVJuMXR5aXlnYjlLT3hsWUZleVZIVFRnaTlVVE9xNzVjNktNOGpnc2ZPRUhhbTdJdmVIVWEzb1duZ3dYNGw2cVNRSHJQUWVkTzNpNmdyaVR3Tk8tOUNVd0hXU2tZSEVPT3ZRMkpDMGRfbm5EdThVU3B1cllvNkhlSHVZZjBmcmZNQnZOZld6S3ZZbkN6bHJRd2NKX1pwaWxKUk1LRDlCS2xSZFZFZ3FoZ1MwckpBbUVCSDd1d3dxcnp4TmdSeHc?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CYRX Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for CryoPort, Inc. (CYRX) stock for 2027, based on analyst opinions. It details current stock performance, historical highs and lows, financial metrics like market capitalization, earnings, revenue, and EBITDA, and does not sugges", "url": "https://www.tradingview.com/symbols/NASDAQ-CYRX/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T05:12:12", "published_display": "26 Jun 2026 05:12", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of CryoPort, Inc. \u2013 GETTEX:CKX", "summary": "This article focuses on the enterprise value to EBITDA forward for CryoPort, Inc. (GETTEX:CKX). It appears to be a stub or data-point article from TradingView, providing financial metrics for the company within the Air Freight/Couriers sector. The content includes a brief mention", "url": "https://www.tradingview.com/symbols/GETTEX-CKX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T05:12:12", "published_display": "26 Jun 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort to Provide IntegriCell Cryopreservation Services for Verismo's Development Programs", "summary": "Cryoport Systems, a subsidiary of Cryoport, Inc., has been selected by Verismo Therapeutics to provide IntegriCell Cryopreservation services. These services will support Verismo's clinical Kir-Car T cell therapy programs. This announcement highlights Cryoport's role in supplying ", "url": "https://www.marketscreener.com/news/cryoport-to-provide-integricell-cryopreservation-services-for-verismo-s-development-programs-ce7f5fd8de8bf323", "source_name": "marketscreener.com", "published_at": "2026-06-25T13:10:58", "published_display": "25 Jun 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport's IntegriCell\u00ae Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs", "summary": "Cryoport Systems' IntegriCell cryopreservation services have been selected by Verismo Therapeutics to support its clinical KIR-CAR T cell therapy programs, SynKIR\u2122-110 and SynKIR\u2122-310. This partnership aims to standardize and scale Verismo's cryopreservation processes, ensuring c", "url": "https://www.prnewswire.com/news-releases/cryoports-integricell-cryopreservation-services-selected-by-verismo-therapeutics-to-support-clinical-kir-car-t-cell-therapy-programs-302810192.html", "source_name": "PR Newswire", "published_at": "2026-06-25T12:10:58", "published_display": "25 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport\u2019s IntegriCell selected for Verismo therapy programs By Investing.com", "summary": "Cryoport, Inc. announced that its IntegriCell cryopreservation services have been chosen by Verismo Therapeutics to support two clinical-stage CAR T cell therapy programs, SynKIR-110 and SynKIR-310, which are both in Phase 1 trials. This partnership will include process developme", "url": "https://m.au.investing.com/news/stock-market-news/cryoports-integricell-selected-for-verismo-therapy-programs-93CH-4504703?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-25T12:10:58", "published_display": "25 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport lands Verismo for clinical cell therapy cryopreservation", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPS1FmRFVqNWY5MHFvYVFoQUxlYlVsRlU3WHFweVBrUmR1UGVtLVAyS3pOWkNweW95VWZELTB0M1p1TDMtQTFCSVBEVmFWWDVlaE5QYlk4MmdOS0puNTRXUlJlVmxFa2tkZWgxZl85Tk1uaTFBUXB6NC1sdjB4aUttZXhvUU44WmZUb0R5eHp4SHhQcUxxSnFSTmpjckZQVzhxYVZzREVxd0lvRmRnaTB3dWQwcURUQ1k?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[15-12G] Cryoport, Inc. SEC Filing", "summary": "Cryoport, Inc. filed Form 15-12G with the SEC to terminate or suspend its duty to file reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934. The filing indicates the termination relies on Rule 12g-4(a)(1) and states that the warrants to purchase common stock", "url": "https://www.stocktitan.net/sec-filings/CYRX/15-12g-cryoport-inc-sec-filing-bfd4ff53185d.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:10:09", "published_display": "22 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(CYRX) Movement as an Input in Quant Signal Sets", "summary": "This article from Stock Traders Daily discusses Cryoport Inc. (NASDAQ: CYRX) and its movement within quantitative signal sets. It highlights positive near-term sentiment while noting a weak mid-term bias within a long-term strength context. The analysis provides AI-generated sign", "url": "https://news.stocktradersdaily.com/news_release/9/CYRX_Movement_as_an_Input_in_Quant_Signal_Sets_062226012402_1782105842.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-22T01:24:00", "published_display": "22 Jun 2026 01:24", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Proxy Filing Summary", "summary": "This article summarizes Cryoport's (CYRX) proxy filing, detailing the upcoming annual meeting scheduled for June 6, 2025. Shareholders will vote on the election of six directors, the ratification of Deloitte & Touche LLP as independent auditor, advisory votes on executive compens", "url": "https://quartr.com/events/cryoport-cyrx-proxy-filing_FkZ6Y8zf", "source_name": "Quartr", "published_at": "2026-06-21T09:39:08", "published_display": "21 Jun 2026 09:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Valuation: PE, PB & Fair Value Analysis", "summary": "The article provides a valuation analysis for Cryoport Inc (CYRX), noting its current valuation score is 9.89, ranking 2nd in the Freight & Logistics Services industry. It highlights the company's current P/E ratio of 10.48, which is below its recent high but significantly above ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T17:40:09", "published_display": "18 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Cryoport Inc (CYRX) has an earnings forecast score of 8.60, placing it 8th out of 77 in the Freight & Logistics Services industry. Analysts have an average price target of $13.00, with a consensus \"Buy\" rating based on 10 analysts. The company's expected revenue for the next quar", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T05:41:20", "published_display": "18 Jun 2026 05:41", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Cryoport Inc (CYRX), focusing on its support and resistance levels, various technical indicators, and moving averages. As of June 18, 2026, CYRX has a price momentum score of 7.08 and is trading between a resistance level of $16.58 an", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/technical", "source_name": "TradingKey", "published_at": "2026-06-18T05:41:20", "published_display": "18 Jun 2026 05:41", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Cryoport Inc (CYRX), listing major shareholders and their proportional holdings, as well as an analysis of shareholder types. It also provides institutional shareholding data over several quarters and recent shareholder activity w", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T05:11:03", "published_display": "18 Jun 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical data on dividends and stock splits for Cryoport Inc (CYRX). It states that no dividend data or stock split information is available for the company over the past five years. The page also includes current stock information such as market cap, P/E ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T06:40:30", "published_display": "17 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Cryoport Inc (CYRX) for fiscal year 2025. It segments the company's revenue into business lines, including Life Science products, BioLogistics solutions, and BioStorage/Bioservices, and also by geographical regions: Americas,", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T05:40:30", "published_display": "17 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Financial Health: Profitability & Balance Sheet Analysis", "summary": "The article analyzes the financial health of Cryoport Inc (CYRX), giving it a financial score of 7.34, ranking 42 out of 77 in its industry. It highlights the company's robust financial status and average operating efficiency, noting a 16.47% year-over-year increase in quarterly ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T05:09:09", "published_display": "17 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Inc (CYRX) Institutional Confidence", "summary": "Cryoport Inc (CYRX) has an institutional shareholding score of 10.00, placing it first among 77 companies in the Freight & Logistics Services industry. The latest institutional shareholding proportion is 97.68%, despite a quarter-over-quarter decrease of 16.78%. First Eagle Inves", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cyrx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T05:09:09", "published_display": "17 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Stock Fair Value Rises After Analysts Revisit Bioservices Outlook", "summary": "Analysts have increased Cryoport's (CYRX) fair value per share to US$15.61 from US$13.61, indicating a more positive outlook on the stock's intrinsic worth. This change is driven by recent reports focusing on bioservices operations, with discussion around differentiated offerings", "url": "https://sg.finance.yahoo.com/news/cryoport-cyrx-stock-fair-value-121105049.html", "source_name": "Market source", "published_at": "2026-06-13T12:09:18", "published_display": "13 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 78, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport chief digital and tech officer sells $507,563 in stock", "summary": "Cryoport's Chief Digital and Tech Officer, Edward J. Zecchini, sold approximately $507,563 worth of company stock across two days in June 2026. These transactions involved acquiring shares through option exercises at $4.80 each and then selling them at significantly higher market", "url": "https://www.investing.com/news/insider-trading-news/cryoport-chief-digital-and-tech-officer-sells-507563-in-stock-93CH-4740742", "source_name": "Investing.com", "published_at": "2026-06-13T03:40:22", "published_display": "13 Jun 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) tech chief exercises 35,000 options and sells shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPei1hTWU4cnZPUUZxd1hrS3Z2UEtLZlQ1ZXJtU0tFcHk2RFItX2dvMFdyMXRwTEZ4RWV3MnZsMkd1d0dNMTRhQjNydnVkNjYyREp2d1VHeUlKMGFBdmhIUF91TnlKWmZHemxLbXVqUmxzR2ZvbzlxNVhlcEZLU0FjOUpuQ2ozS29CTGgwMk55NHpVWGM4VXIyMlIwcVdMLUtMSWlfZWNNVWtwdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Cryoport, Inc. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNTHU0U0lmZ2RybFA2cG9TUV9YV0s0ODJ0UzRzZWxjSkJhdm16UWp5ZzZ6cXp1NUNxU0dFNTdLZ0VrdWNtQlZab2FmVHhGaXVSZXp0SDcxcDU5eHdsQWljV2xTSHZaZzhpeDlMcVRyWi1qbktWLWxFOGRVSi1tMFc1ZzZiaGRYRkdpVVdqdnl2VHRwNE0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Senior VP Robert Stefanovich Sold A Bunch Of Shares In Cryoport", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Insider Sold Shares Worth $2,756,984, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cryoport-insider-sold-shares-worth-071646428.html", "source_name": "MT Newswires", "published_at": "2026-06-09T07:16:46+00:00", "published_display": "09 Jun 2026 07:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (NASDAQ: CYRX) investors approve directors, pay and expanded equity plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQelp0NUpxNmhfaGJmc3NxVmJJLWdQVnpSbF9CZ3A1WnJCa3hHeVAwazVmWEtGaHVrdlZJOUR3MndYaGhxV3BTVzVKR3VxWXpxbXN6M2FrR1l0VE8xb2lZOHRRZVdsLU9PbjVvWExrRXBNWTdTUGxGakFiMXVnUUo0LU9NSUY1UnBzbTJPWHFWRE5JYkRxSFRRUHAwZ1o2cHNwZFFF?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham Raises Price Target on CryoPort to $15 From $13, Keeps Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/needham-raises-price-target-cryoport-124604962.html", "source_name": "MT Newswires", "published_at": "2026-05-05T12:46:04+00:00", "published_display": "05 May 2026 12:46", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/44a34789-b1b2-370b-9db5-af843fa8fec7/cryoport%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-05T00:23:26+00:00", "published_display": "05 May 2026 00:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/58796537-ecc4-3eae-8df9-8324684f873f/cryoport-%28cyrx%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-04T22:21:22+00:00", "published_display": "04 May 2026 22:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/9edadef3-689d-3887-9775-c9f49f5254f7/cryoport-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-04T22:17:51+00:00", "published_display": "04 May 2026 22:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Q2 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/7ae8f1e9-c196-3458-b26d-28141f1ecb63/cryoport-%28cyrx%29-q2-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-04T20:29:20+00:00", "published_display": "04 May 2026 20:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOZmRGa0RZaDYxSHpBMTdOSnNYZE43WGZWNXlfVEVrTnRCZmo2dnRIbDVDT3JkVnhsb001WXg5NzJ3dHRGbG1fb0k2bFNLY3lpMWtPM0ZFanZ3TldMWWoyd0J1c0V6b1ZKT0pfenpXTU5MbENPWVNEQ3ZoSmlaRVc3elhzTlRORVlpSW1yaHhRZXREalVSWjhFajF1VEZXSDg3bWFEN1BhOVRXekJhREE?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRYOPORT ($CYRX) Releases Q1 2026 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNUDNNN3U4RnZvVmdQdVFCOUZvMEhvMzJGZTNHYkFFSFFNTjdmYWgyZW5SdWNsNHMweGJEbmhqRktQRkQyWkJ5bUtIclNkSzhOb094dXVJbWFSdFJjTDh6UjhPLVUyUlRHWWVILW5CNDItb0kzUUhvV3pLZXFwTHBxamc5V2JsazRJQXZJeVhydXdBblM0RmF1V2hOT0Y?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2RfNFpRckdadF83VzNvekI1bTVXWDBBRmNtbjkwMXhrYU1TZDA5d2JxTDd0dl9oRUNSS2hkQXl3Q2R6Nlhtb2JrdmFTLVNqeS1aLVBadUlHZS1HT1RLbzhOakFyQlBHOTgwVV9sWkd4b2dVV2dGaFJ4QXFpbk9ZT0NhbDRRZmRQN2REZ3lEamczaTRzYUNQaQ?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Cryoport (CYRX) Story Is Shifting With Fresh Analyst Coverage And Valuation Tweaks", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQSlV5MG9KNUxWMUNuUVcwT29DSl93WUgzWnBuNTFjVDFQOVNpUllqR0RocWVjbnlsbURkTk1GVldXanF6T2U0TWpRTEtRVkNwNHhGMjNjdkVoTzFwc0Zrak1BRDQySWQySHdtTUhTOU04MUZQZUVnQ1VsaGhBRVVDWl9Tckp2alBMRnZqbnY4LVhPX1daVDB2TzhoUDFjZXF4?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport schedules May 4 earnings release, 5 p.m. investor Q&A", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbUR0YzVSa0VpN0dTd3FpSXVyT0dieUY2dE83TEpDZFQzV0hiNlhWbndHVTJtOHNDRm9ZOEFMcXNURXZKNkdIOEx5WExYTzJ0TXc0UkszcG1SVzNyQWFUcEpJME9GY0lBWVpjelAyTzM2WFhHZXdZUk5zUU9RMVVXcWY1YTEtMm5KRzEyUy1hZVdHVXdoMWltblFQYUVPN3B1MFNXSnVMaGFrM1Z2NmpSc3Y2TUdrLWIwSlZN?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven (NASDAQ:CYRX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQcWNBbmZRa05RX1U5eVNjd012ZHlwd05udmJLZzJmRkRzN0dGX1RUNXg0Mk1Dem1ITUU0RVZtbFJ3ZVF0cHdadW1WX0ZDakpIOEVRbjU5NXpfTFpFOEI4ckxvcHhkdkFCQW9lSnlMendPSEgzY3RLcnZTZWVTdWQwT1dsSWtSMDMyNG80LXZZa2ZQel8yUEJmRFZYSjJTZENEalJTTWg2NFJWd2xkcGlybGhZLU1xT1E?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Freezing gene therapies for 760 trials: Cryoport's $176M year", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQMUNvOXVDa0ozclAwN3lyby1TOWxBQVoxNGhCQk5xSVlqREhWZE1xR1NEcGlWcTc0R1FDSU9uOElaTDJIbHNkZ0ZjdXR5UWFNRzR2b0VNaENJbHp3YUlHX3V4bkFaOGdhMXk4dVJWNVBYbEo4aWJqOFotckxmWG1VckZuR1hSSWR3WEExeGkyU2sxOVBGbHpDWE5nd3F3cGkzdU5teXFhY3JNSmtfaGR3cmlWRTJwdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort Inc. (CYRX) Stock Rises on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNV3hMRk5scWFDcTd3ZWZrT1g4aWxCVWlHNWgyYTg0bFg1VFRaeEF4QWUwanhDclZIWTFCRDdhOVJPYkl5UjA1eUdEaDlMXzF5aVRSbjJvMWlCU1VEMmJRRmdNdTR4TzV4djlHMVlCN0tjTk5QOVphTzJfcFRoVFFkMTVaRGdHeUhDdUl6WUJfOVQ1d28?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cryoport (CYRX) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9pOTBUa2ZNbjFtV2U4YU8yZThnOTQxUkJVQzB2SHg0LWF6OE1VYWVLMlFzd2VQTXFxTmYzcGNsd2hSR0FEVWlpV3lSSUFoZw?oc=5", "source_name": "Stock Titan", "published_at": "2025-11-04T08:00:00+00:00", "published_display": "04 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOLVdNcXphS3JyTGVRUmlnanJkOGpwVnFGQ0JGZWM2U3hFZzFYX0tGZnd4QTRsRWRENFB1cDlHeFNrZGxJSDNSLUk5cTVSdXdWRl9TZXZKUGEtRHI5T2NDYUtqMW5fenJhTHlISDlJdVZFaDdIYmZlRTd5RGhSTmhWZGpKOHJfMmFrX1F3MFc2Z1lQLWNtUHhVQm9fYzVtVURfYlB3N0d3SkM4S09pTmRmMEpaT0Q?oc=5", "source_name": "Stock Titan", "published_at": "2024-09-25T07:00:00+00:00", "published_display": "25 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CryoPort (CYRX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE0ybV9mbktYbkpCaFFhNURSSEl6aGVnYk9YYzNRcVNtc3did1pUUWh3MkxQeDduam1NVlc2VXBSM0NTdzBOa0VHRUdKLWR3UWVGRkhUYm41emFzZw?oc=5", "source_name": "MarketBeat", "published_at": "2017-03-30T00:11:36+00:00", "published_display": "30 Mar 2017 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 84, "total_relevant": 53, "sentiment_summary": {"positive": 18, "negative": 2, "neutral": 33, "score": 58, "total": 53, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 14.1, "count": 25}, {"event": "earnings", "label": "Earnings", "weight": 9.35, "count": 17}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 18, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 16.17, "latest_week": "2026-07-10", "one_week_move": 4.4, "four_week_move": 10.6, "twelve_week_move": 56.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.104372, "market_dynamics_buy_signal": false, "relative_strength": 37.289152, "fair_value_gap": 55.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 53.9927, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.4% over one week, +10.6% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 9}, {"label": "TradingKey", "count": 8}, {"label": "TradingView", "count": 6}, {"label": "MarketBeat", "count": 5}, {"label": "Market source", "count": 3}, {"label": "Stock Traders Daily", "count": 2}, {"label": "Quartr", "count": 2}, {"label": "PR Newswire", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 53}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 25}, {"label": "Earnings", "count": 17}, {"label": "Analyst action", "count": 4}, {"label": "Deals and strategy", "count": 3}, {"label": "Balance sheet", "count": 1}, {"label": "Macro sensitivity", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "53", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+4.4% over one week, +10.6% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "(CYRX) as a Liquidity Pulse for Institutional Tactics"}], "updated_at": "2026-07-16T00:37:19.350485+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}